Picture of GeneDx Holdings logo

WGS — GeneDx Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

GeneDx Holdings Corp reports results for the quarter ended in September 30 - Earnings Summary

* GeneDx Holdings Corp  WGS.OQ  reported quarterly adjusted
earnings of 4 cents​​ per share for the quarter ended September
30, higher than the same quarter last year, when the company
reported EPS of -82 cents.  The mean expectation of six analysts
for the quarter was for a loss of 21 cents per share. Wall
Street expected results to range from -27 cents to -16 cents per
share.
    * Revenue rose 44.2% to $76.87 million from a year ago;
analysts
expected $64.99 million. 
    * GeneDx Holdings Corp's reported EPS for the quarter was a
loss
of 31 cents​.
    * The company reported a quarterly loss of $8.31 million.
    * GeneDx Holdings Corp shares had risen by 32.1% this
quarter and
gained 1,938.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the healthcare
facilities & services peer group is also "buy"

Wall Street's median 12-month price target for GeneDx Holdings
Corp is $49.50 
This summary was machine generated from LSEG data October 29 at
02:15 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.21          0.04           Beat
 Jun. 30 2024      -0.30          -0.10          Beat
 Mar. 31 2024      -0.67          -0.33          Beat
 Dec. 31 2023      -0.75          -0.69          Beat

Recent news on GeneDx Holdings

See all news